Literature DB >> 15864137

Vitamin D receptor gene polymorphisms, particularly the novel A-1012G promoter polymorphism, are associated with vitamin D3 responsiveness and non-familial susceptibility in psoriasis.

J A Halsall1, J E Osborne, J H Pringle, P E Hutchinson.   

Abstract

Psoriasis is a genetically determined disease characterized by hyperproliferation and disordered maturation of the epidermis. Th1 lymphocytes are implicated in its pathogenesis. The vitamin D receptor (VDR) is a candidate modifying gene, having immunosuppressive effects and being involved in anti-proliferative and pro-differentiation pathways in keratinocytes. There is suggestive evidence that the A allele of the A-1012G polymorphism is associated with down-regulation of the Th1 response, via GATA-3. The F and T alleles of Fok1 and Taq1 have been associated with increased VDR activity. The present study aimed to test the hypothesis that the A allele of A-1012G is protective for occurrence and severity of psoriasis and enhances therapeutic response to vitamin D analogues and that these effects would be additive to those of Fok1 and Taq1. The study group comprised 206 psoriasis patients who had received topical calcipotriol treatment and 80 controls. There was no significant linkage disequilibrium between any pair of the three polymorphic sites (P=0.3-0.8). The A, F and T alleles were positively associated with calcipotriol response: AA genotype (compared to AG/GG), odds ratio (OR)=2.18 (P=0.04); TT, OR=1.97 (P=0.03); AAFF genotype combination, OR=4.11 (P=0.03); AATT, OR=5.64 (P=0.005); and FFTT, OR=3.22 (P=0.01). Comparing patients without, to patients with, a family history of psoriasis, the A allele was under represented (P=0.01) and the AAFF genotype combination even more so (compared to residual genotypes) (OR=0.24; P=0.005). AAFF was also under-represented in patients without a family history compared to controls (OR=0.31; P=0.04). There were no associations of family history with Fok1 and Taq1. There were no associations of severity of psoriasis with any polymorphism. In conclusion, the A-1012G, Fok1 and Taq1 VDR polymorphisms were associated with response to calcipotriol. A-1012G and Fok1 were associated with susceptibility to non-familial psoriasis.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15864137     DOI: 10.1097/01213011-200505000-00011

Source DB:  PubMed          Journal:  Pharmacogenet Genomics        ISSN: 1744-6872            Impact factor:   2.089


  19 in total

Review 1.  Leprosy as a genetic disease.

Authors:  Andrea Alter; Audrey Grant; Laurent Abel; Alexandre Alcaïs; Erwin Schurr
Journal:  Mamm Genome       Date:  2010-10-09       Impact factor: 2.957

2.  The CCHCR1 (HCR) gene is relevant for skin steroidogenesis and downregulated in cultured psoriatic keratinocytes.

Authors:  Inkeri Tiala; Sari Suomela; Jari Huuhtanen; Janica Wakkinen; Maarit Hölttä-Vuori; Kati Kainu; Sirpa Ranta; Ursula Turpeinen; Esa Hämäläinen; Hong Jiao; Seija-Liisa Karvonen; Elina Ikonen; Juha Kere; Ulpu Saarialho-Kere; Outi Elomaa
Journal:  J Mol Med (Berl)       Date:  2007-01-13       Impact factor: 4.599

Review 3.  The latest advances in pharmacogenetics and pharmacogenomics in the treatment of psoriasis.

Authors:  Caitriona Ryan; Alan Menter; Richard B Warren
Journal:  Mol Diagn Ther       Date:  2010-04-01       Impact factor: 4.074

4.  Promoter and 3'-untranslated-region haplotypes in the vitamin d receptor gene predispose to osteoporotic fracture: the rotterdam study.

Authors:  Yue Fang; Joyce B J van Meurs; Arnold d'Alesio; Mila Jhamai; Hongyan Zhao; Fernando Rivadeneira; Albert Hofman; Johannes P T van Leeuwen; Frédéric Jehan; Huibert A P Pols; André G Uitterlinden
Journal:  Am J Hum Genet       Date:  2005-09-26       Impact factor: 11.025

5.  Vitamin D receptor (VDR) polymorphisms and skin cancer: A systematic review.

Authors:  Nicole Denzer; Thomas Vogt; Jörg Reichrath
Journal:  Dermatoendocrinol       Date:  2011-07-01

6.  Vitamin D receptor ApaI, TaqI, BsmI, and FokI polymorphisms and psoriasis susceptibility: a meta-analysis.

Authors:  Young Ho Lee; Sung Jae Choi; Jong Dae Ji; Gwan Gyu Song
Journal:  Mol Biol Rep       Date:  2012-06       Impact factor: 2.316

7.  Vitamin D3 receptor polymorphisms regulate T cells and T cell-dependent inflammatory diseases.

Authors:  Gonzalo Fernandez Lahore; Bruno Raposo; Marie Lagerquist; Claes Ohlsson; Pierre Sabatier; Bingze Xu; Mike Aoun; Jaime James; Xiaojie Cai; Roman A Zubarev; Kutty Selva Nandakumar; Rikard Holmdahl
Journal:  Proc Natl Acad Sci U S A       Date:  2020-09-21       Impact factor: 11.205

8.  Genetic polymorphisms of vitamin D receptor (VDR) in Fabry disease.

Authors:  Michael Teitcher; Sarah Weinerman; Catharina Whybra; Michael Beck; Nir Sharon; Deborah Elstein; Gheona Altarescu
Journal:  Genetica       Date:  2008-02-16       Impact factor: 1.082

9.  Vitamin D receptor haplotypes protect against development of colorectal cancer.

Authors:  Jana Flügge; Solveigh Krusekopf; Mark Goldammer; Elena Osswald; Werner Terhalle; Uwe Malzahn; Ivar Roots
Journal:  Eur J Clin Pharmacol       Date:  2007-09-20       Impact factor: 2.953

10.  Multifunctional enhancers regulate mouse and human vitamin D receptor gene transcription.

Authors:  Lee A Zella; Mark B Meyer; Robert D Nerenz; Seong Min Lee; Melissa L Martowicz; J Wesley Pike
Journal:  Mol Endocrinol       Date:  2009-11-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.